Justin Kisner

Special Counsel

Justin has extensive experience advising public companies with respect to federal securities and corporate governance matters, with a focus on US Securities and Exchange Commission (SEC) and stock exchange reporting and disclosure requirements. He also counsels on the technical and interpretive aspects of SEC reporting and disclosure as they relate to business combinations involving mergers, tender offers, exchange offers and going-private transactions, and the proxy, beneficial ownership, and Section 16 provisions of the Securities Exchange Act of 1934. Justin leverages his extensive knowledge and SEC experience to help the firm’s lawyers and clients navigate complex issues arising under the federal securities laws, as well as the reporting and disclosure requirements and other SEC rules that affect public disclosure, domestic and cross-border M&A, and capital markets transactions.

Download full bio 


  • Horizon Therapeutics to Be Acquired by Amgen for Approximately $28 Billion 


    Quality time with family

    All things health and fitness


    Italian cooking


  • University of San Diego School of Law
    JD, 2012

  • University of San Diego
    BA, International Relations
    cum laude, 2008

Admissions & Credentials


District of Columbia